ConductScience.org, home
Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
API referenceFor AI assistants

Trial · NCT02599324

Participant flow81

How many started, completed or left each group, period by period.

1 to 20 of 81

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Phase 1bSTARTEDCohort 1 (RCC): Ibrutinib 560 mg + Everolimus3
Phase 1bSTARTEDCohort 1 (RCC): Ibrutinib 840 mg + Everolimus7
Phase 1bSTARTEDCohort 2 (UC): Ibrutinib 560 mg + Paclitaxel4
Phase 1bSTARTEDCohort 2 (UC): Ibrutinib 840 mg + Paclitaxel10
Phase 1bSTARTEDCohort 3 (GA): Ibrutinib 560 mg + Docetaxel21
Phase 1bSTARTEDCohort 4 (CRC): Ibrutinib 560 mg + Cetuximab8
Phase 1bSTARTEDCohort 4 (CRC): Ibrutinib 840 mg + Cetuximab12
Phase 1bSTARTEDCohort 5 (UC): Ibrutinib 840 mg10
Phase 1bSTARTEDCohort 6 (UC): Ibrutinib 560 mg + Pembrolizumab17
Phase 1bCOMPLETEDCohort 1 (RCC): Ibrutinib 560 mg + Everolimus3
Phase 1bCOMPLETEDCohort 1 (RCC): Ibrutinib 840 mg + Everolimus7
Phase 1bCOMPLETEDCohort 2 (UC): Ibrutinib 560 mg + Paclitaxel4
Phase 1bCOMPLETEDCohort 2 (UC): Ibrutinib 840 mg + Paclitaxel10
Phase 1bCOMPLETEDCohort 3 (GA): Ibrutinib 560 mg + Docetaxel21
Phase 1bCOMPLETEDCohort 4 (CRC): Ibrutinib 560 mg + Cetuximab8
Phase 1bCOMPLETEDCohort 4 (CRC): Ibrutinib 840 mg + Cetuximab12
Phase 1bCOMPLETEDCohort 5 (UC): Ibrutinib 840 mg10
Phase 1bCOMPLETEDCohort 6 (UC): Ibrutinib 560 mg + Pembrolizumab17
Phase 1bNOT COMPLETEDCohort 1 (RCC): Ibrutinib 560 mg + Everolimus0
Phase 1bNOT COMPLETEDCohort 1 (RCC): Ibrutinib 840 mg + Everolimus0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02599324/flow

API referenceFor AI assistants